Insulin Glargine U-300 Max 00955-2900
Generic: Insulin Glargine
Product NDC
00955-2900- Manufacturer
- Sanofi-Aventis U.s. Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 1, 2023
- Listing Expires
- December 31, 2026
- Application
- BLA206538
Need to source Insulin Glargine U-300 Max? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Insulin Glargine | 300 [iU]/mL |
Drug Class
Insulin Analog [EPC]Insulin Analog [EPC]Insulin [CS]
Packaging Options(1)
2 SYRINGE in 1 CARTON (0955-2900-02) / 3 mL in 1 SYRINGE (0955-2900-01)